A study of the relationship between rear-of-wheel particle emissions and close-proximity tire/road noise of a passenger car

Non-exhaust particulate emissions and road traffic noise will continue to constitute significant threats to the environment and human health during the 21st century. In the EU alone, >60 million adults are subjected to unhealthy levels of vehicle noise, while over 200,000 premature deaths are caused by chronic exposure to excessive concentrations of fine particles, with road traffic being a key source. Although these pollutants share common sources and can affect the same targets, studies have often treated their emissions separately. This study establishes both the phenomenological and mathematical relationships between tire/road noise (TRN) and rear-of-wheel particle (RoWP) emissions. Information from test track measurements, coupled with correlation-based models, enables linking TRN with RoWP emissions through variables such as vehicle speed and pavement properties, including macro-texture scales. A careful examination of the data reveals that pavement macro-texture acts as a crucible in which TRN and RoWP emissions are generated in an interrelated manner. However, at speeds over 70-80 km/h, the depletion of readily mobilizable RoWP fractions, followed by the emergence of refractory (hard-to-mobilize) circum-/super-micron RoWP fractions from resuspension (which accompanies the intensification of air-pumping TRN generation mechanisms), marks a loss of this interdependence. These results, supplemented by valuable insights into the particulate emission performance of pavements, serve to outline future air quality challenges and provide a basis for the simplified monitoring and control (e.g. through acoustic measurements) of RoWP emissions.

Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors

The success of cancer immunotherapy depends in part on the strength of antigen recognition by T cells. Here, we characterize the T cell receptor (TCR) functional (antigen sensitivity) and structural (monomeric pMHC-TCR off-rates) avidities of 371 CD8 T cell clones specific for neoantigens, tumor-associated antigens (TAAs) or viral antigens isolated from tumors or blood of patients and healthy donors. T cells from tumors exhibit stronger functional and structural avidity than their blood counterparts. Relative to TAA, neoantigen-specific T cells are of higher structural avidity and, consistently, are preferentially detected in tumors. Effective tumor infiltration in mice models is associated with high structural avidity and CXCR3 expression. Based on TCR biophysicochemical properties, we derive and apply an in silico model predicting TCR structural avidity and validate the enrichment in high avidity T cells in patients' tumors. These observations indicate a direct relationship between neoantigen recognition, T cell functionality and tumor infiltration. These results delineate a rational approach to identify potent T cells for personalized cancer immunotherapy.

TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs

T cell receptor (TCR) technologies, including repertoire analyses and T cell engineering, are increasingly important in the clinical management of cellular immunity in cancer, transplantation, and other immune diseases. However, sensitive and reliable methods for repertoire analyses and TCR cloning are still lacking. Here, we report on SEQTR, a high-throughput approach to analyze human and mouse repertoires that is more sensitive, reproducible, and accurate as compared with commonly used assays, and thus more reliably captures the complexity of blood and tumor TCR repertoires. We also present a TCR cloning strategy to specifically amplify TCRs from T cell populations. Positioned downstream of single-cell or bulk TCR sequencing, it allows time- and cost-effective discovery, cloning, screening, and engineering of tumor-specific TCRs. Together, these methods will accelerate TCR repertoire analyses in discovery, translational, and clinical settings and permit fast TCR engineering for cellular therapies.

Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes

The recognition of pathogen or cancer-specific epitopes by CD8⁺ T cells is crucial for the clearance of infections and the response to cancer immunotherapy. This process requires epitopes to be presented on class I human leukocyte antigen (HLA-I) molecules and recognized by the T-cell receptor (TCR). Machine learning models capturing these two aspects of immune recognition are key to improve epitope predictions. Here, we assembled a high-quality dataset of naturally presented HLA-I ligands and experimentally verified neo-epitopes. We then integrated these data in a refined computational framework to predict antigen presentation (MixMHCpred2.2) and TCR recognition (PRIME2.0). The depth of our training data and the algorithmic developments resulted in improved predictions of HLA-I ligands and neo-epitopes. Prospectively applying our tools to SARS-CoV-2 proteins revealed several epitopes. TCR sequencing identified a monoclonal response in effector/memory CD8⁺ T cells against one of these epitopes and cross-reactivity with the homologous peptides from other coronaviruses.

Novel Methodology to Recover Road Surface Height Maps from Illuminated Scene through Convolutional Neural Networks

Road surface properties have a major impact on pavement's life service conditions. Nowadays, contactless techniques are widely used to monitor road surfaces due to their portability and high precision. Among the different possibilities, laser profilometers are widely used, even though they have two major drawbacks: spatial information is missed and the cost of the equipment is considerable. The scope of this work is to show the methodology used to develop a fast and low-cost system using images taken with a commercial camera to recover the height information of the road surface using Convolutional Neural Networks. Hence, the dataset was created ad hoc. Based on photometric theory, a closed black-box with four light sources positioned around the surface sample was built. The surface was provided with markers in order to link the ground truth measurements carried out with a laser profilometer and their corresponding intensity values. The proposed network was trained, validated and tested on the created dataset. Three loss functions where studied. The results showed the Binary Cross Entropy loss to be the most performing and the best overall on the reconstruction task. The methodology described in this study shows the feasibility of a low-cost system using commercial cameras based on Artificial Intelligence.

A differential process mining analysis of COVID-19 management for cancer patients

During the acute phase of the COVID-19 pandemic, hospitals faced a challenge to manage patients, especially those with other comorbidities and medical needs, such as cancer patients. Here, we use Process Mining to analyze real-world therapeutic pathways in a cohort of 1182 cancer patients of the Lausanne University Hospital following COVID-19 infection. The algorithm builds trees representing sequences of coarse-grained events such as Home, Hospitalization, Intensive Care and Death. The same trees can also show probability of death or time-to-event statistics in each node. We introduce a new tool, called Differential Process Mining, which enables comparison of two patient strata in each node of the tree, in terms of hits and death rate, together with a statistical significance test. We thus compare management of COVID-19 patients with an active cancer in the first vs. second COVID-19 waves to quantify hospital adaptation to the pandemic. We also compare patients having undergone systemic therapy within 1 year to the rest of the cohort to understand the impact of an active cancer and/or its treatment on COVID-19 outcome. This study demonstrates the value of Process Mining to analyze complex event-based real-world data and generate hypotheses on hospital resource management or on clinical patient care.

In-Tire Distributed Optical Fiber (DOF) Sensor for the Load Assessment of Light Vehicles in Static Conditions

Modern vehicles are using control and safety driving algorithms fed by various evaluations such as wheel speeds or road environmental conditions. Wheel load evaluation could be useful for such algorithms, particularly for extreme vehicle loading or uneven loads. For now, smart tires are only equipped by tire pressure monitoring systems (TPMS) and temperature sensors. Manufacturers are still working on in-tire sensors, such as load sensors, to create the next generation of smart tires. The present work aims at demonstrating that a static tire instrumented with an internal optical fiber allows the wheel load estimation for every wheel angular position. Experiments have been carried out with a static tire loaded with a hydraulic press and instrumented with both an internal optical fiber and an embedded laser. Load estimation is performed both from tire deflection and contact patch length evaluations. For several applied loads from 2800 to 4800 N, optical fiber load estimation is realized with a relative error of 1% to 3%, almost as precisely as that with the embedded laser, but with the advantage of the load estimation regardless of the wheel angular position. In perspective, the developed methodology based on an in-tire optical fiber could be used for continuous wheel load estimation for moving vehicles, benefiting control and on-board safety systems.

Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting

CD8+ T cell recognition of peptide epitopes plays a central role in immune responses against pathogens and tumors. However, the rules that govern which peptides are truly recognized by existing T cell receptors (TCRs) remain poorly understood, precluding accurate predictions of neo-epitopes for cancer immunotherapy. Here, we capitalize on recent (neo-)epitope data to train a predictor of immunogenic epitopes (PRIME), which captures molecular properties of both antigen presentation and TCR recognition. PRIME not only improves prioritization of neo-epitopes but also correlates with T cell potency and unravels biophysical determinants of TCR recognition that we experimentally validate. Analysis of cancer genomics data reveals that recurrent mutations tend to be less frequent in patients where they are predicted to be immunogenic, providing further evidence for immunoediting in human cancer. PRIME will facilitate identification of pathogen epitopes in infectious diseases and neo-epitopes in cancer immunotherapy.